|1.||Arcasoy, Murat O: 11 articles (05/2011 - 04/2002)|
|2.||Noguchi, Constance Tom: 7 articles (04/2015 - 01/2002)|
|3.||Acs, Geza: 6 articles (04/2009 - 09/2002)|
|4.||Tóvári, József: 5 articles (12/2015 - 08/2005)|
|5.||Tímár, József: 4 articles (12/2015 - 08/2005)|
|6.||Döme, Balázs: 4 articles (12/2015 - 01/2007)|
|7.||Fu, Rong: 4 articles (01/2015 - 08/2011)|
|8.||Elliott, Steve: 4 articles (01/2015 - 03/2006)|
|9.||Liu, Hui: 4 articles (01/2015 - 08/2011)|
|10.||Begley, C Glenn: 4 articles (01/2015 - 03/2006)|
04/01/2008 - "Still, following the finding that the erythropoietin receptor (EpoR) is expressed by several tumor cells types and after the trials reporting that the recombinant cytokine can adversely affect tumor progression and patient survival, the clinical safety of rHuEpo administration to neoplastic patients has recently been questioned. "
01/01/2008 - "Recent studies indicated that, besides erythroid progenitor cells, tumor and endothelial cells express erythropoietin receptor (EPOR) as well; therefore, rHuEPO may affect their functions. "
08/15/2007 - "Recent studies showed that erythropoietin receptor (EpoR) is expressed on many cancer cells. "
11/25/2005 - "Recent studies indicate that cancer cells express erythropoietin receptor (EpoR). "
11/01/2005 - "Erythropoietin receptor expression in canine mammary tumor: an immunohistochemical study."
01/01/2013 - "Helix B surface peptide administered after insult of ischemia reperfusion improved renal function, structure and apoptosis through beta common receptor/erythropoietin receptor and PI3K/Akt pathway in a murine model."
12/01/2015 - "Without an active regulatory feedback loop, increased blood viscosity could lead to a vicious cycle of ischemia, increased erythropoiesis, further increases of blood viscosity, decreased tissue perfusion with worsened ischemia, further increases in red cell mass, etc. We suggest that an increase in blood viscosity is detected by mechanoreceptors in the left ventricle which upregulate expression of cardiac natriuretic peptides and soluble erythropoietin receptor. "
01/01/2008 - "Lately, research has focused on the nonhemopoietic effects of erythropoietin against tissue ischemia due to the unexpected observations of erythropoietin receptor expression by various cells, such as endothelial cells, neuronal cells, cardiac myocytes, and vascular smooth muscle cells. "
03/16/2007 - "Important role of erythropoietin receptor to promote VEGF expression and angiogenesis in peripheral ischemia in mice."
10/19/2001 - "Erythropoietin receptor-mediated inhibition of exocytotic glutamate release confers neuroprotection during chemical ischemia."
10/01/2011 - "Targeting the erythropoietin receptor on glioma cells reduces tumour growth."
12/22/2015 - "Erythropoietin receptor positive cell lines U87 human glioma and MCF-7 human breast carcinoma were studied. "
02/10/2015 - "Silencing erythropoietin receptor on glioma cells reinforces efficacy of temozolomide and X-rays through senescence and mitotic catastrophe."
09/01/2015 - "The aim of this study was to evaluate the putative pathological roles of the erythropoietin receptor (EPOR) in AA-induced anemia in both AA nephropathy zebrafish and cultured human renal tubular cells (HK2). "
07/15/2008 - "Preclinical animal studies have shown that Ab12.6, an agonistic human Ab targeting the erythropoietin receptor (EPOR), exhibits several potential dosing and safety features that make it an attractive clinical candidate for the treatment of anemia. "
05/01/2004 - "Pharmacokinetic tracer kinetics analysis of changes in erythropoietin receptor population in phlebotomy-induced anemia and bone marrow ablation."
10/01/2002 - "[Possible role of soluble erythropoietin receptors in renal anemia]."
07/15/2001 - "Mice lacking the erythropoietin receptor exhibit severe anemia and die at about embryonic day 13.5. "
|3.||Messenger RNA (mRNA)
|5.||Proteins (Proteins, Gene)
|6.||Carbonic Anhydrases (Carbonic Anhydrase)
|9.||Facilitative Glucose Transport Proteins (Glucose Transporter)
|1.||Drug Therapy (Chemotherapy)
|2.||Heterologous Transplantation (Xenotransplantation)
|5.||Transplantation (Transplant Recipients)